Close

Cara Therapeutics (CARA) Commences CR845 Phase 2b Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/26/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. TMUS
10. GOOGL


Go back to Cara Therapeutics (CARA) Commences CR845 Phase 2b Enrollment
CARA THERAPEUTICS (NASDAQ: CARA) Delayed: 0.70 +0.03 (4.48%)
Previous Close $0.67    52 Week High $17.69 
Open $0.66    52 Week Low $4.26 
Day High $0.72    P/E N/A 
Day Low $0.64    EPS $-0.42 
Volume 319,087